GeneReach Biotechnology
Taipei, Taiwan· Est.
Taiwanese point‑of‑care molecular diagnostics company leveraging insulated isothermal PCR technology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Taiwanese point‑of‑care molecular diagnostics company leveraging insulated isothermal PCR technology.
Technology Platform
Insulated isothermal PCR (iiPCR) combined with magnetic particle nucleic acid extraction for rapid, portable molecular diagnostics.
Opportunities
Expansion of point‑of‑care testing in emerging markets and development of multiplexed infectious disease panels.
Risk Factors
Regulatory approval delays and intense competition from larger diagnostic manufacturers.
Competitive Landscape
Competes with Cepheid, BioFire, and Abbott rapid PCR platforms, differentiating through insulated isothermal technology and integrated consumable kits.